tiprankstipranks
Advertisement
Advertisement

APVO Stock Latest News

Aptevo Therapeutics appoints Janatpour as SVP, CSO
The FlyAptevo Therapeutics appoints Janatpour as SVP, CSO
6d ago
APVO
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
PremiumCompany Announcements
Aptevo Forms Strategic Radiopharmaceutical Collaboration with Niowave
7d ago
8K
APVO
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
PremiumThe Fly
Aptevo, Niowave launch collab for radiopharmaceutical oncology programs
7d ago
APVO
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
PremiumThe Fly
Aptevo Therapeutics reports Q1 cash and cash equivalents $14.5M
21d ago
APVO
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
PremiumThe Fly
Aptevo reports 87% clinical benefit in frontline AML patients in RAINIER trial
27d ago
APVO
Aptevo Highlights Strong Phase 1b AML Trial Results
PremiumCompany AnnouncementsAptevo Highlights Strong Phase 1b AML Trial Results
28d ago
8K
APVO
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
Premium
The Fly
Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
2M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
Premium
The Fly
Aptevo Therapeutics sees cash runway into 4Q26
2M ago
APVO
Aptevo Reports Promising Interim Data for AML Therapy
PremiumCompany Announcements
Aptevo Reports Promising Interim Data for AML Therapy
3M ago
8K
APVO
Aptevo Therapeutics announces interim data for mipletamig combination
PremiumThe Fly
Aptevo Therapeutics announces interim data for mipletamig combination
3M ago
APVO
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
PremiumCompany Announcements
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
3M ago
8K
APVO
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
PremiumCompany Announcements
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
4M ago
8K
APVO
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
PremiumThe FlyAptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
4M ago
APVO
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
Premium
The Fly
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
4M ago
APVO
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
Premium
Company Announcements
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
5M ago
8K
APVO
Aptevo Therapeutics secures $60M equity line of credit
PremiumThe Fly
Aptevo Therapeutics secures $60M equity line of credit
5M ago
APVO
Aptevo Therapeutics trading halted, news pending
PremiumThe Fly
Aptevo Therapeutics trading halted, news pending
5M ago
APVO
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
PremiumCompany Announcements
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
5M ago
8K
APVO
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
5M ago
WOK
ACET
Aptevo Therapeutics Announces Promising RAINIER Trial Results
PremiumCompany AnnouncementsAptevo Therapeutics Announces Promising RAINIER Trial Results
6M ago
8K
APVO
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
Premium
The Fly
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
6M ago
APVO
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
Premium
The Fly
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
7M ago
APVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >